PD 165929, with the CAS number 185215-75-2, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. PD 165929 is known to act as a selective inhibitor, targeting specific enzymes or receptors within biological systems, which may lead to its efficacy in treating certain diseases. The compound's solubility, stability, and pharmacokinetic properties are crucial for its development as a pharmaceutical agent. Additionally, its safety profile and potential side effects are important considerations in the context of drug development. Research into PD 165929 may involve various analytical techniques to assess its purity, potency, and mechanism of action, contributing to a deeper understanding of its role in therapeutic applications. Overall, PD 165929 represents a significant area of interest for researchers exploring new treatment options in medicine.

PD 165929 is a Bombesin BB1 selective antagonist.

PD 165929

185215-75-2: PD 165929, with the CAS number 185215-75-2, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. PD 165929 is known to act as a selective inhibitor, targeting specific enzymes or receptors within biological systems, which may lead to its efficacy in treating certain diseases. The compound's solubility, stability, and pharmacokinetic properties are crucial for its development as a pharmaceutical agent. Additionally, its safety profile and potential side effects are important considerations in the context of drug development. Research into PD 165929 may involve various analytical techniques to assess its purity, potency, and mechanism of action, contributing to a deeper understanding of its role in therapeutic applications. Overall, PD 165929 represents a significant area of interest for researchers exploring new treatment options in medicine.

PD 165929 is a selective antagonist of Bombesin BB1.

CAS 185215-75-2

PD 165929

PD 165929

Ref: TM-T28338